BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Nov. 24, 2020

View Archived Issues
"Rising Man" statue outside Medtronic HQ

Medtronic beats revenue consensus, declines to provide guidance

Medtronic plc reported second quarter worldwide revenue of $7.647 billion, a decrease of 0.8% as reported and 1.5% on an organic basis. Analysts noted, however, that the figure beat the consensus of $7.08 billion. It also exceeded Wells Fargo’s $7.12 billion estimate. With the continued uncertainty related to the ongoing COVID-19 pandemic, the Dublin-based company did not provide formal annual or quarterly financial guidance. Still, the need for ventilators pushed the company ahead. Read More
Workflow steps

Correlia Biosystems nabs $7 million in series A financing

Following steady expansion of its base among global pharmaceutical companies, Correlia Biosystems Inc. has secured the capital needed to make its nanotechnology-based immunoassay platform commercially available. The company received an infusion of $7 million in series A financing in a round led by Neotribe Ventures with participation by Cota Capital, the Regents of the University of California and others. Read More
Colorectal cancer

Test sensitivity, specificity debated in Medicare colorectal cancer biomarker coverage draft

The draft version of the U.S. Medicare national coverage analysis for blood-based biomarker tests for colorectal cancer (CRC) engendered a large body of support, but several stakeholders recommended that the Centers for Medicare & Medicaid Services (CMS) avoid prescriptiveness regarding the sensitivity and specificity for any tests that would be covered under the policy. Read More
Product image

Carmat wins non-dilutive financing of $11.8M from the French government

PARIS – Carmat SA has closed an $11.8 million loan in the form of a government-backed loan from a French banking syndicate. In an environment made uncertain by the COVID-19 crisis, Carmat will be able to continue its clinical development program on its total artificial heart, undisturbed. “This financing facility contributes to securing our cash position and extends our financial visibility through to the third quarter of 2021,” Stéphane Piat, CEO of Carmat, told BioWorld. Read More
Precision device in use

Limaca Medical secures $1.25M to advance Precision biopsy tool

Endoscopic ultrasound-guided biopsy startup Limaca Medical Ltd. has raised $1.25 million of a $1.5 million round to advance its next-generation Precision device. The company said it will use the funds to complete first-in-human procedures, conduct postmarket clinical studies and gain regulatory approvals of Precision for gastrointestinal (GI) system and adjacent organ tumors. Read More

HHS seeks feedback on pandemic-driven policymaking

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA lists entities recognized under ASCA program. Read More

Appointments and advancements for Nov. 24, 2020

New hires and promotions in the med-tech industry, including: Ibex Medical, Ieso Digital, Quanta Dialysis, Signifier Medical, United Health Products. Read More

Financings for Nov. 24, 2020

Med-tech firms raising money in public or private financings, including: Voluntis, Well Health. Read More

In the clinic for Nov. 24, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: NaviFUS. Read More

Other news to note for Nov. 24, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aspen Surgical, Baxter, Babybe, Blue Earth Diagnostics, Bodycad, Canon Medical Systems, Cloudbreak, Cohealo, Curtis Mathes, DarwinAI, Emphysys, Exactech, Flirtey, Fluidx, Glassbeam, Gigcapital2, Harpak-Ulma, Insightec, Ixlayer, Lockheed Martin, Median Technologies, Natus Medical, Nucleis Radiopharmaceuticals, Pack Health, Paramit, Premier, Protek Medical Products, Storm ID, Todos Medical, Uphealth, Vault Health, Zebra Medical Vision. Read More

Regulatory actions for Nov. 24, 2020

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apyx Medical, Braid Health, Cardiawave, Cepheid, Fluidigm, Neuronetics, Zymo Research. Read More

BioWorld MedTech’s Oncology Extra for Nov. 24, 2020

Keeping you up to date on recent developments in oncology, including: Nanoparticles may blunt TRIM37’s impact on metastasis in triple-negative breast cancer; Glycolysis inhibition via collateral lethality; Making exceptional responders unexceptional; Protons may spare cancer patients a hit to the heart. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 11, 2025.
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for Feb. 10, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing